Assembly Biosciences (STU:V7B) Cyclically Adjusted Book per Share: €50.93 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:V7B Assembly Biosciences Inc STU:V7B
32 GF Score
Price €28.95
! 4 Warning Signs
View Full Analysis

What is Assembly Biosciences Cyclically Adjusted Book per Share?

Assembly Biosciences STU:V7B -1.03% 32 Cyclically Adjusted Book per Share is €50.93 as of Jun. 2026. GuruFocus rates STU:V7B with a GF Score™ of 32/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Assembly Biosciences's adjusted book value per share for the three months ended in Jun. 2026 was €13.365. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €50.93 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Assembly Biosciences's average Cyclically Adjusted Book Growth Rate was -11.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -10.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Assembly Biosciences was 10.10% per year. The lowest was -10.00% per year. And the median was -7.30% per year.

As of today (2026-08-25), Assembly Biosciences's current stock price is €28.95. Assembly Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €50.93. Assembly Biosciences's Cyclically Adjusted PB Ratio of today is 0.57.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Assembly Biosciences was 5.22. The lowest was 0.10. And the median was 0.40.


Assembly Biosciences  (STU:V7B) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Assembly Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=28.95/50.93
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Assembly Biosciences was 5.22. The lowest was 0.10. And the median was 0.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Assembly Biosciences Cyclically Adjusted Book per Share Related Terms


Assembly Biosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Assembly Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assembly Biosciences Cyclically Adjusted Book per Share Chart

Assembly Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.67 75.79 69.31 61.93 48.48

Assembly Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.59 49.68 48.48 50.76 50.93

STU:V7B vs ZURA, ARVN, ARTV: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Assembly Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assembly Biosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's Cyclically Adjusted PB Ratio falls into.


STU:V7B
32GF Score
Assembly Biosciences Inc STU:V7B
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Assembly Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Assembly Biosciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=13.365/333.9520*333.9520
=13.365

Current CPI (Jun. 2026) = 333.9520.

Assembly Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201609 55.909 241.428 77.335
201612 52.696 241.432 72.890
201703 43.988 243.801 60.254
201706 34.773 244.955 47.407
201709 27.291 246.819 36.925
201712 56.964 246.524 77.166
201803 48.871 249.554 65.399
201806 44.395 251.989 58.835
201809 92.660 252.439 122.580
201812 87.136 251.233 115.826
201903 79.147 254.202 103.978
201906 72.352 256.143 94.330
201909 65.905 256.759 85.719
201912 90.636 256.974 117.787
202003 83.799 258.115 108.420
202006 86.759 257.797 112.388
202009 83.708 260.280 107.401
202012 69.730 260.474 89.400
202103 62.144 264.877 78.350
202106 52.738 271.696 64.822
202109 48.674 274.310 59.257
202112 37.282 278.802 44.657
202203 33.230 287.504 38.599
202206 29.103 296.311 32.800
202209 25.601 296.808 28.805
202212 19.150 296.797 21.547
202303 15.154 301.836 16.766
202306 11.603 305.109 12.700
202309 8.914 307.789 9.672
202312 6.873 306.746 7.483
202403 5.470 312.332 5.849
202406 5.077 314.175 5.397
202409 3.687 315.301 3.905
202412 4.272 315.605 4.520
202503 3.294 319.799 3.440
202506 2.045 322.561 2.117
202509 9.841 324.800 10.118
202512 11.136 324.054 11.476
202603 10.810 330.213 10.932
202606 13.365 333.952 13.365

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €50.93 mean?
Assembly Biosciences (STU:V7B) has a Cyclically Adjusted Book per Share of €50.93 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Assembly Biosciences and its competitors.
Is Assembly Biosciences' Cyclically Adjusted Book per Share too high?
Assembly Biosciences' current Cyclically Adjusted Book per Share is €50.93. Overall, Assembly Biosciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Assembly Biosciences' Cyclically Adjusted Book per Share compare to ZURA and ARVN?
Assembly Biosciences' Cyclically Adjusted Book per Share of €50.93 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Assembly Biosciences and its competitors. Assembly Biosciences's current Cyclically Adjusted Book per Share is €50.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Assembly Biosciences stock overvalued right now?
Assembly Biosciences (STU:V7B) has a current Cyclically Adjusted Book per Share of €50.93. The current Cyclically Adjusted Book per Share is €50.93. Assembly Biosciences' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Assembly Biosciences (STU:V7B), the current Cyclically Adjusted Book per Share is €50.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Assembly Biosciences Business Description

Other Exchanges ASMB:USA
Address Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
32GF Score

Get the complete analysis for STU:V7B

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.95
Price